Moleculin to Showcase New Annamycin Data at AACR Conference on Pancreatic Cancer and Two European Scientific Meetings

ConferenceAnnamycinPositive

AI Analysis

Summary

Moleculin will present new Annamycin data at the AACR conference and two European scientific meetings, examining the drug's biodistribution, mechanism of action against topoisomerase II, and antitumor activity in pancreatic cancer.

Importance:3/10

Sentiment:

0.30

Annamycinpancreatic cancerAACR conferencetopoisomerase IIdata presentation

Read the original article

Published by GlobeNewswire Pharma on September 14, 2026 12:35 PM

Read Original